A landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early ...
By Dennis Thompson HealthDay ReporterFRIDAY, June 5, 2026 (HealthDay News) — An already available two-pill combo treats ...
HealthDay News — Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of ...
Pooled analysis of 24 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who resumed revumenib post-transplant shows favorable ...
The ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia ...
On the first Sunday in June, people across the country recognize Cancer Survivors Day. Around a thousand people gathered in ...
A study of women undergoing breast imaging showed a significantly lower incidence of breast cancer in those who had a history ...
Acute myeloid leukemia (AML) is a multifaceted and devastating blood cancer characterized by frequent genetic mutations, ...
Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors ...
Researchers sought to determine whether adding selinexor to chemotherapeutic induction and consolidation regimen would improve outcomes in AML.
Researchers sought to determine whether a single dose of tisagenlecleucel following standard lymphodepletion chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results